Cogent Biosciences, Inc. — All Filings
584 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
10-Q/A
144
3
3/A
4
4/A
424B3
424B4
424B5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DEFM14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
POS AM
PRE 14A
PRER14A
S-1
S-1/A
S-3
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC TO-I
SC TO-I/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G | — | 0001831942-25-000016 | Aug 14, 2025 | — |
| 8-K | 8-K | 0000950170-25-102433 | Aug 5, 2025 | — |
| 10-Q | 10-Q | 0000950170-25-102440 | Aug 5, 2025 | Jun 30, 2025 |
| 4 | OWNERSHIP DOCUMENT | 0001104659-25-067758 | Jul 14, 2025 | Jul 10, 2025 |
| SCHEDULE 13D/A | — | 0001104659-25-067760 | Jul 14, 2025 | — |
| SCHEDULE 13G | — | 0001193805-25-001001 | Jul 11, 2025 | — |
| 8-K | 8-K | 0001193125-25-157390 | Jul 10, 2025 | Jul 7, 2025 |
| 424B5 | 424B5 | 0001193125-25-157121 | Jul 9, 2025 | — |
| 424B5 | 424B5 | 0001193125-25-156654 | Jul 8, 2025 | — |
| 8-K | 8-K | 0001193125-25-155811 | Jul 7, 2025 | — |
| 4 | 4 | 0000950170-25-092976 | Jul 2, 2025 | Jul 1, 2025 |
| 8-K | 8-K | 0001193125-25-138813 | Jun 11, 2025 | — |
| 4 | 4 | 0000950170-25-082365 | Jun 5, 2025 | Jun 4, 2025 |
| 4 | 4 | 0000950170-25-082368 | Jun 5, 2025 | Jun 4, 2025 |
| 4 | 4 | 0000950170-25-082364 | Jun 5, 2025 | Jun 4, 2025 |
| 4 | 4 | 0000950170-25-082348 | Jun 5, 2025 | Jun 4, 2025 |
| 4 | 4 | 0000950170-25-082374 | Jun 5, 2025 | Jun 4, 2025 |
| 8-K | 8-K | 0001193125-25-135337 | Jun 5, 2025 | Jun 4, 2025 |
| 4 | 4 | 0000950170-25-082349 | Jun 5, 2025 | Jun 4, 2025 |
| SCHEDULE 13G/A | — | 0001104659-25-049526 | May 15, 2025 | — |
| EFFECT | — | 9999999995-25-001478 | May 9, 2025 | — |
| 10-Q | 10-Q | 0000950170-25-064005 | May 6, 2025 | Mar 31, 2025 |
| 8-K | 8-K | 0000950170-25-063987 | May 6, 2025 | — |
| POS AM | POS AM | 0001193125-25-113367 | May 6, 2025 | — |
| 424B5 | 424B5 | 0001193125-25-113402 | May 6, 2025 | — |
| DEF 14A | DEF 14A | 0001193125-25-089237 | Apr 22, 2025 | Jun 4, 2025 |
| DEFA14A | DEFA14A | 0001193125-25-089248 | Apr 22, 2025 | — |
| ARS | ARS | 0001193125-25-089258 | Apr 22, 2025 | Dec 31, 2024 |
| SCHEDULE 13G/A | — | 0001415889-25-010591 | Apr 11, 2025 | — |
| PRE 14A | PRE 14A | 0001193125-25-079139 | Apr 11, 2025 | Jun 4, 2025 |
| 4 | 4 | 0000950170-25-050374 | Apr 3, 2025 | Apr 1, 2025 |
| 10-K | 10-K | 0000950170-25-026115 | Feb 25, 2025 | Dec 31, 2024 |
| S-8 | S-8 | 0001193125-25-035115 | Feb 25, 2025 | — |
| 8-K | 8-K | 0000950170-25-026103 | Feb 25, 2025 | — |
| SCHEDULE 13G/A | — | 0000902664-25-001038 | Feb 14, 2025 | — |
| SCHEDULE 13G | — | 0001104659-25-012215 | Feb 12, 2025 | — |
| SCHEDULE 13G/A | — | 0000315066-25-000872 | Feb 12, 2025 | — |
| 4 | 4 | 0000950170-25-009266 | Jan 27, 2025 | Jan 23, 2025 |
| 4 | 4 | 0000950170-25-009258 | Jan 27, 2025 | Jan 23, 2025 |
| 4 | 4 | 0000950170-25-009271 | Jan 27, 2025 | Jan 23, 2025 |
| 4 | 4 | 0000950170-25-009256 | Jan 27, 2025 | Jan 23, 2025 |
| 4 | 4 | 0000950170-25-009257 | Jan 27, 2025 | Jan 23, 2025 |
| 4 | 4 | 0000950170-25-009263 | Jan 27, 2025 | Jan 23, 2025 |
| 4 | 4 | 0000950170-25-005630 | Jan 15, 2025 | Jan 14, 2025 |
| 4 | 4 | 0000950170-25-001210 | Jan 3, 2025 | Jan 1, 2025 |
| 8-K | 8-K | 0001193125-24-273393 | Dec 9, 2024 | Dec 8, 2024 |
| SC 13G/A | — | 0000919574-24-006725 | Nov 14, 2024 | — |
| SC 13G/A | KYNAM CAPITAL MANAGEMENT, LP | 0001085146-24-005824 | Nov 14, 2024 | — |
| SC 13G/A | — | 0001493152-24-045813 | Nov 14, 2024 | — |
| SC 13G/A | SC 13G/A | 0001104659-24-119314 | Nov 14, 2024 | — |